News

Orchard Therapeutics to Reimburse Access to Libmeldy for MLD Patients in Sweden

February 27, 2023

Orchard Therapeutics has announced an agreement which will enable reimbursed access to Libmeldy for all eligible MLD patients in Sweden.

Bio-Rad’s New StarBright Blue and Yellow Dyes Enhance Multiplex Flow Cytometry

February 27, 2023

Bio-Rad’s newly launched StarBright Blue and StarBright Yellow dyes are intended for use in various flow cytometry applications.

Eurofins Viracor Launches Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients

February 27, 2023

Eurofins Viracor ExPeCT CAR-T qPCR assay is a tool designed for monitoring and optimizating CAR-T therapies.

Moderna and Life Edit Therapeutics Enter Gene Editing Collaboration

February 24, 2023

Moderna will leverage Life Edit’s suite of gene editing technologies to advance development of in vivo gene editing therapies.

FDA Approves Sanofi Hemophilia Treatment

February 24, 2023

Sanofi’s once-weekly replacement therapy is FDA-approved for prevention and treatment of bleeding episodes in people with hemophilia A.

AbbVie and Capsida Strike $674 Million Gene Therapy Development Deal

February 24, 2023

AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.

Predictive Oncology and Cvergenx Enter Genomics-Based Personalized Therapy Collaboration

February 24, 2023

The goal of this collaboration is to develop an approach to personalized radiotherapy and drug discovery that is based in genomics and artificial intelligence.

IRBs Need More Monitoring

February 23, 2023

GAO calls for more oversight of institutional review boards in clinical trials.

FDA Recommends Recall of Artificial Eye Ointment for Potential Bacterial Contamination

February 22, 2023

This warning is the second on top of a previous warning not to purchase or use EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears due to potential bacterial contamination.

Agilent Gains Design Support from CRB for Manufacturing Facility Expansion

February 22, 2023

Agilent’s therapeutic nucleic acids facility gains architectural design support from CRB.